Akorn Stock Price and Value Analysis

Should you buy Akorn stock? (NasdaqGS:AKRX). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This stock looks overpriced.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This company pays no dividend.

AKRX Free Cash Flow Trend

Based on historical returns, we believe that Akorn can grow its free cash at a rate of about 1%. That's positive!

Free Cash Flow trendline for AKRX
Free Cash Flow trendline for Akorn

Inside the AKRX Numbers

AKRX Price
(Akorn stock price per share)
[?] AKRX Fair Price
(based on intrinsic value)
[?] AKRX Safety Price (based on a variable margin of safety) $15.40
[?] PE Ratio versus Sector 168% higher than other Healthcare stocks
[?] PE Ratio versus Industry 8% higher than other Drugs - Generic stocks
[?] Cash Yield 8.86%
[?] Free Cash Flow Jitter 155%
[?] Dividend Yield 0%

Is Akorn Stock on Sale?

We believe that Akorn may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Akorn looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy AKRX Stock?

Does Akorn have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.